SCHEMBL3377977

SCHEMBL3377977

O=C(c1cccc(N(Cc2ccccc2)S(=O)(=O)c2ccccc2)c1)N1CCCC(c2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 2/20 0.51
HPGD P15428 2/20 0.51
PROKR1 Q8TCW9 2/20 0.49
PARP14 Q460N5 1/20 0.48
PARP10 Q53GL7 1/20 0.48
TSHR P16473 1/20 0.48
MEN1 O00255 1/20 0.46
HIF1A Q16665 1/20 0.46
PKM P14618 2/20 0.45
MYC P01106 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377147 0.90 PROKR1 (0.52) LMNAALDH1A1KMT2AHPGDPROKR1
SCHEMBL303313 0.89 LMNA (0.57) LMNAALDH1A1KMT2AHPGDPARP14
SCHEMBL3376238 0.83 LMNA (0.50) LMNAALDH1A1KMT2AHPGDTSHR
SCHEMBL13065011 0.83 LMNA (0.55) LMNAALDH1A1KMT2AHPGDTSHR
SCHEMBL13064516 0.81 LMNA (0.60) LMNAALDH1A1KMT2AHPGDTSHR
SCHEMBL302689 0.80 LMNA (0.37) LMNAALDH1A1KMT2AHPGDPROKR1
SCHEMBL303740 0.80 LMNA (0.47) LMNAALDH1A1KMT2AHPGDPARP14
SCHEMBL3377152 0.80 LMNA (0.60) LMNAALDH1A1KMT2AHPGDTSHR
SCHEMBL13065202 0.80 CNR2 (0.60) LMNAALDH1A1KMT2AHPGDTSHR
SCHEMBL3377438 0.79 LMNA (0.54) LMNAALDH1A1KMT2AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342177-B1 NOVEL POTASSIUM CHANNEL BLOCKERS JAPAN TOBACCO INC (JP) 2017-02-15 EP claimed
US-9073834-B2 Potassium channel blockers XENTION LIMITED (GB) 2015-07-07 US claimed
US-20140221337-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2014-08-07 US claimed
US-20100087428-A1 Novel Potassium Channel Blockers XENTION LIMITED (GB) 2010-04-08 US claimed
EP-2342177-B1 NOVEL POTASSIUM CHANNEL BLOCKERS JAPAN TOBACCO INC (JP) 2017-02-15 EP disclosed
US-9447033-B2 Potassium channel blockers JAPAN TOBACCO INC. (JP) 2016-09-20 US disclosed
US-20150259282-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2015-09-17 US disclosed
US-9073834-B2 Potassium channel blockers XENTION LIMITED (GB) 2015-07-07 US disclosed
US-20140221337-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2014-08-07 US disclosed
US-8673901-B2 Potassium channel blockers XENTION LIMITED (GB) 2014-03-18 US disclosed
US-20100087428-A1 Novel Potassium Channel Blockers XENTION LIMITED (GB) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221337-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 LMNA 1619/4885ALDH1A1 1360/4885KMT2A 386/4885
US-20100087428-A1 Novel Potassium Channel Blockers HCN4, SCN2B, KCNH2 LMNA 2145/4885ALDH1A1 3795/4885KMT2A 1511/4885
US-20150259282-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 LMNA 1619/4885ALDH1A1 1360/4885KMT2A 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.